Oragenics Inc (OGEN) Stock Crosses 200-Day MA: A Bullish Sign?

Oragenics Inc (NYSEAMERICAN:OGEN) stock continues to gain for the third consecutive session on Friday. At the time of writing, OGEN stock is up as much as 25% and trading at the high point of the day at $0.92 on very high volume.

Oragenics Inc (OGEN) Stock Crosses 200-Day MA: A Bullish Sign?

After a deep correction of over 50% from February’s high, the stock has rebounded strongly this week. In fact, the stock is up about 43% from Wednesday’s low $0.64. Nevertheless, the stock is still up 80% so far this year.

Related:  Will GBS (GBS) New Invention Boost The Stock To Unimaginable Extremes?

Earlier in March, the company announced an agreement with Biodextris Inc. for the use of three intranasal mucosal adjuvants in the Company’s Terra CoV-2 vaccine against COVID-19.

Well, a sharp recovery after a deep correction is always healthy and more importantly, the stock has gained back above its 200-day moving average of $0.79. Now the next level to keep an eye on would be $0.97 – which is its 50-Day moving average.






Related:  Relief Therapeutics (RLFTF) Stock is On The Verge Of Breakout: What Next?


Jack Dawkins

Finance and Tech Contributor